Literature DB >> 25689821

ADIOL protects against 3-NP-induced neurotoxicity in rats: Possible impact of its anti-oxidant, anti-inflammatory and anti-apoptotic actions.

Diana M F Hanna1, Mariane G Tadros2, Amani E Khalifa1.   

Abstract

Huntington's disease (HD) is a progressive neurodegenerative disorder with a wide spectrum of cognitive, behavioral and motor abnormalities. The mitochondrial toxin 3-nitropropionic acid (3-NP) effectively induces specific behavioral changes and selective striatal lesions similar to that observed in HD. Some neurosteroids, synthesized in neurons and glial cells, previously showed neuroprotective abilities. 5-Androstene-3β-17β-diol (ADIOL) is a major metabolite of dehydroepiandrosterone (DHEA) with previously reported anti-inflammatory, anti-apoptotic and neuroprotective activities. The neuroprotective potential of ADIOL in HD was not previously investigated. Therefore, the present study investigated the neuroprotective effects of ADIOL against 3-NP-induced behavioral changes, oxidative stress, inflammation and apoptosis. Intraperitoneal administration of 3-NP (20mg/kg) for 4 consecutive days in rats caused significant loss in body weight, reduced prepulse inhibition (PPI) of acoustic startle response, locomotor hypoactivity with altered cortical/striatal histological structure, increased cortical/striatal oxidative stress, inflammation and apoptosis. Administration of ADIOL (25mg/kg, s.c.) for two days before 3-NP significantly attenuated the reduction in body weights and PPI, increased locomotor activity and restored cortical/striatal histological structure nearly to normal. Moreover, it displayed anti-oxidant, anti-inflammatory and anti-apoptotic activities as evidenced by the elevation of cortical and striatal reduced glutathione levels, reductions of cortical and striatal malondialdehyde, striatal tumor necrosis factor alpha and interleukin-6 levels. Only a small number of iNOS and caspase-3 positive cells were detected in sections from rats pretreated with ADIOL. This study suggests a potential neuroprotective role of ADIOL against 3-NP-induced Huntington's disease-like manifestations. Such neuroprotection can be attributed to its anti-oxidant, anti-inflammatory and anti-apoptotic activities.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3-Nitropropionic acid; ADIOL; Apoptosis; Neuroinflammation; Prepulse inhibition

Mesh:

Substances:

Year:  2015        PMID: 25689821     DOI: 10.1016/j.pnpbp.2015.02.005

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  10 in total

1.  Role of Rho Kinase Inhibition in the Protective Effect of Fasudil and Simvastatin Against 3-Nitropropionic Acid-Induced Striatal Neurodegeneration and Mitochondrial Dysfunction in Rats.

Authors:  Lamiaa A Ahmed; Hebatallah A Darwish; Rania M Abdelsalam; HebatAllah A Amin
Journal:  Mol Neurobiol       Date:  2015-07-15       Impact factor: 5.590

2.  Antioxidant and antiapoptotic actions of selegiline protect against 3-NP-induced neurotoxicity in rats.

Authors:  Sara A Wahdan; Mariane G Tadros; Amani E Khalifa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-06-23       Impact factor: 3.000

3.  Ginsenoside Rg1 exerts neuroprotective effects in 3-nitropronpionic acid-induced mouse model of Huntington's disease via suppressing MAPKs and NF-κB pathways in the striatum.

Authors:  Xiong Yang; Shi-Feng Chu; Zhen-Zhen Wang; Fang-Fang Li; Yu-He Yuan; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2020-11-19       Impact factor: 7.169

4.  The sigma-1 receptor-zinc finger protein 179 pathway protects against hydrogen peroxide-induced cell injury.

Authors:  Tzu-Chieh Su; Shu-Hui Lin; Pin-Tse Lee; Shiu-Hwa Yeh; Tsung-Hsun Hsieh; Szu-Yi Chou; Tsung-Ping Su; Jan-Jong Hung; Wen-Chang Chang; Yi-Chao Lee; Jian-Ying Chuang
Journal:  Neuropharmacology       Date:  2016-01-11       Impact factor: 5.250

5.  Androstenediol Reduces Demyelination-Induced Axonopathy in the Rat Corpus Callosum: Impact on Microglial Polarization.

Authors:  Samah Kalakh; Abdeslam Mouihate
Journal:  Front Cell Neurosci       Date:  2017-02-23       Impact factor: 5.505

6.  Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease.

Authors:  Hanan El-Abhar; Mai A Abd El Fattah; Walaa Wadie; Dalia M El-Tanbouly
Journal:  PLoS One       Date:  2018-09-27       Impact factor: 3.240

Review 7.  Central intracrine DHEA synthesis in ageing-related neuroinflammation and neurodegeneration: therapeutic potential?

Authors:  Y S L Powrie; C Smith
Journal:  J Neuroinflammation       Date:  2018-10-16       Impact factor: 8.322

8.  Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6/2 mouse model of Huntington's disease.

Authors:  Carmela Giampà; Alessandra Alvino; Marta Magatti; Antonietta R Silini; Antonella Cardinale; Emanuela Paldino; Francesca R Fusco; Ornella Parolini
Journal:  J Cell Mol Med       Date:  2018-12-25       Impact factor: 5.310

9.  Protective effect of Xuebijing injection on D-galactosamine- and lipopolysaccharide-induced acute liver injury in rats through the regulation of p38 MAPK, MMP-9 and HO-1 expression by increasing TIPE2 expression.

Authors:  Ming-Wei Liu; Rong Liu; Hai-Yin Wu; Wei Zhang; Jing Xia; Min-Na Dong; Wen Yu; Qiang Wang; Feng-Mei Xie; Rui Wang; Yun-Qiao Huang; Chuan-Yun Qian
Journal:  Int J Mol Med       Date:  2016-09-23       Impact factor: 4.101

10.  Beneficial effect of rice bran extract against 3-nitropropionic acid induced experimental Huntington's disease in rats.

Authors:  Navneet Kaur; Sumit Jamwal; Rahul Deshmukh; Vinod Gauttam; Puneet Kumar
Journal:  Toxicol Rep       Date:  2015-08-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.